Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 155

1.

Antifungal activity against Candida species of the selective serotonin-reuptake inhibitor, sertraline.

Lass-Flörl C, Dierich MP, Fuchs D, Semenitz E, Ledochowski M.

Clin Infect Dis. 2001 Dec 15;33(12):E135-6. Epub 2001 Nov 7.

PMID:
11700578
2.

[Sertraline in the treatment of premenstrual dysphoric disorder].

Culav-Sumić J, Skocilić Z, Jukić V.

Lijec Vjesn. 1999 Jul-Aug;121(7-8):234-8. Croatian.

PMID:
10573958
3.

Treatment of premenstrual dysphoric disorder with luteal phase dosing of sertraline.

Halbreich U, Kahn LS.

Expert Opin Pharmacother. 2003 Nov;4(11):2065-78. Review.

PMID:
14596660
4.

Intermittent versus continuous sertraline therapy in the treatment of premenstrual dysphoric disorders.

Alpay FB, Turhan NO.

Int J Fertil Womens Med. 2001 Jul-Aug;46(4):228-31.

PMID:
11563834
5.
6.

Clinical characteristics of vulvovaginal candidiasis and antifungal susceptibilities of Candida species isolates among patients in southern China from 2003 to 2006.

Fan SR, Liu XP, Li JW.

J Obstet Gynaecol Res. 2008 Aug;34(4):561-6. doi: 10.1111/j.1447-0756.2008.00817.x.

PMID:
18937710
7.

The selective serotonin reuptake inhibitor sertraline: its profile and use in psychiatric disorders.

MacQueen G, Born L, Steiner M.

CNS Drug Rev. 2001 Spring;7(1):1-24. Review.

8.

Vulvovaginal candidiasis in a Flemish patient population.

De Vos MM, Cuenca-Estrella M, Boekhout T, Theelen B, Matthijs N, Bauters T, Nailis H, Dhont MA, Rodriguez-Tudela JL, Nelis HJ.

Clin Microbiol Infect. 2005 Dec;11(12):1005-11.

9.

Interaction of sertraline with Candida species selectively attenuates fungal virulence in vitro.

Lass-Flörl C, Ledochowski M, Fuchs D, Speth C, Kacani L, Dierich MP, Fuchs A, Würzner R.

FEMS Immunol Med Microbiol. 2003 Jan 21;35(1):11-5.

10.

Premenstrual dysphoria and the serotonin system: pathophysiology and treatment.

Steiner M, Pearlstein T.

J Clin Psychiatry. 2000;61 Suppl 12:17-21. Review.

11.

Antifungal properties of selective serotonin reuptake inhibitors against Aspergillus species in vitro.

Lass-Flörl C, Dierich MP, Fuchs D, Semenitz E, Jenewein I, Ledochowski M.

J Antimicrob Chemother. 2001 Dec;48(6):775-9.

PMID:
11733460
12.

Sertraline in the treatment of premenstrual dysphoric disorder.

Yonkers KA, Halbreich U, Freeman E, Brown C, Pearlstein T.

Psychopharmacol Bull. 1996;32(1):41-6.

PMID:
8927673
13.

Premenstrual dysphoric disorder: treatment with sertraline, neuropsychological effects, and flight status.

Kratz K, Anderson S, Poppen B.

Aviat Space Environ Med. 2007 May;78(5 Suppl):B138-43.

PMID:
17547314
14.

Pattern of Candida species isolated from patients with diabetes mellitus and vulvovaginal candidiasis and their response to single dose oral fluconazole therapy.

Goswami D, Goswami R, Banerjee U, Dadhwal V, Miglani S, Lattif AA, Kochupillai N.

J Infect. 2006 Feb;52(2):111-7.

PMID:
15908007
15.

Treatment of premenstrual dysphoric disorder with selective serotonin reuptake inhibitors.

Luisi AF, Pawasauskas JE.

Pharmacotherapy. 2003 Sep;23(9):1131-40. Review.

PMID:
14524645
16.

Is sertraline an effective therapy for premenstrual dysphoric disorder?

Fernandes O, Por CP, Evans MF.

Can Fam Physician. 1998 Apr;44:765-7. No abstract available.

17.

Low-dose sertraline in the treatment of moderate-to-severe premenstrual syndrome: efficacy of 3 dosing strategies.

Kornstein SG, Pearlstein TB, Fayyad R, Farfel GM, Gillespie JA.

J Clin Psychiatry. 2006 Oct;67(10):1624-32.

PMID:
17107257
18.
19.

Selective serotonin reuptake inhibitors and treatment of premenstrual dysphoric disorder.

Finfgeld DL.

Perspect Psychiatr Care. 2002 Apr-Jun;38(2):50-60. Review.

PMID:
12132631
20.

Cost-effectiveness analysis of treatments for premenstrual dysphoric disorder.

Rendas-Baum R, Yang M, Gricar J, Wallenstein GV.

Appl Health Econ Health Policy. 2010;8(2):129-40. doi: 10.2165/11532210-000000000-00000.

PMID:
20175591

Supplemental Content

Support Center